Retinitis Pigmentosa clinical trials at UC Davis

1 research study open to eligible people

Showing trials for

  • Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy

    “We hope to learn more about the safety and feasibility of using your own (autologous) stem cells extracted from your bone marrow.”

    open to eligible people ages 18-100

    This pilot study is to determine whether it would be safe and feasible to inject CD34+ stem cells from bone marrow into the eye as treatment for patients who are irreversibly blind from various retinal conditions.

    Sacramento 5389489, California 5332921

Our lead scientists for Retinitis Pigmentosa research studies include .

Last updated: